Skip to content

Treatment of urethral stricture through uttarbasti

Evaluation of yoga basti as poorvakarma to dhanwantara taila uttar basti along with calibration in management of mutrotsanga w.s.r. to urethral stricture-an exploratory clinical trial. - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099169
Enrollment
46
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N359- Urethral stricture, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject diagnosed as urethral stricture will be selected. In uroflowmetry, Qmax 3- 14 ml/s will be included. ICD guidelines for urethral stricture 2025 ICD-11-CM Diagnosis Code GC03 and will be considered. ICD 11 TM code for mutrotsanga SM88 will be considered.

Exclusion criteria

Exclusion criteria: Patient having other systemic pathologies like renal failure,uncontrolled diabetes mellitus(Hba1c more than 7) and uncontrolled hypertension (BP more than 140/90). Patients diagnosed with acute urinary tract infection( Dysuria, Frequency, Urgency, hematuria ) grade 3 benign prostatic hyperplasia, or acute/chronic prostatitis confirmed by clinical laboratory assessment. Patient diagnosed with neoplasm of the urinary ,HIV,HCV, VDRL and HBsAg positive patients

Design outcomes

Primary

MeasureTime frame
Reduction in symptoms of urethral strictureTimepoint: 4 weeks

Secondary

MeasureTime frame
1)Improvement in Q-max Uroflowmetry. 2)Reduction in PVRU. Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Jyoti Verma

All India Institute of Ayurveda Sarita Vihar New Delhi

dryogesh.badwe@gmail.com9011060498

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026